Vol 52, No 5 (2021)
Editorial
Published online: 2021-10-28
Cytomegalovirus and invasive fungal disease: trolls of hematopoietic cell transplantation
Acta Haematol Pol 2021;52(5):453-454.
Abstract
Not available
References
- Jędrzejczak WW. Polish hematology: from here to the future. Acta Haematol Pol. 2021; 52(1): 2–3.
- Giebel S, Basak G, Bieniaszewska M, et al. Current status and achievements of Polish haemato-oncology. Acta Haematol Pol. 2021; 52(1): 4–17.
- Styczynski J, Tridello G, Gil L, et al. Prognostic impact of Epstein-Barr virus serostatus in patients with nonmalignant hematological disorders undergoing allogeneic hematopoietic cell transplantation: the study of Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation. Acta Haematol Pol. 2020; 51(2): 73–80.
- Czyżewski K, Sedláček P, Štěrba J, et al. Progress and trends in pediatric hematopoietic cell transplantation in Central-East European countries. Acta Haematol Pol. 2020; 51(3): 142–150.
- Styczyński J, Gałązka P, Czyżewski K, et al. High risk of invasive fungal disease in children undergoing hematopoietic cell transplantation or complex anticancer therapy: the adverse role of post-transplant CMV replication. Acta Haematol Pol. 2021; 52(5): 483–492.
- Gil L, Kałwak K, Piekarska A, et al. Antifungal management in adults and children with hematological malignancies or undergoing hematopoietic cell transplantation: recommendations of Polish Society of Hematology and Blood Transfusion, Polish Society of Pediatric Oncology and Hematology, and Polish Adult Leukemia Study Group, 2020. Acta Haematol Pol. 2020; 51(2): 60–72.
- Styczyński J, Czyżewski K, Frączkiewicz J, et al. Clinical spectrum and outcome of invasive mucormycosis in children and adults: Polish experience of the decade 2010–2019. Acta Haematol Pol. 2020; 51(3): 157–163.
- Styczyński J, Czyżewski K, Ussowicz M, et al. Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers. Acta Haematol Pol. 2020; 51(3): 183–186.
- Czyżewski K, Styczyński J. Real-world experience with letermovir in primary prophylaxis of cytomegalovirus in adult patients after hematopoietic cell transplantation: summary of reported data. Acta Haematol Pol. 2021; 52(3): 182–189.
